에드가 맥빈(Edgar Macbean)

일루미나 R&D 헤드



프로필

Ed MacBean leads market development for Precision Health & Screening within Illumina’s New and Emerging Opportunities Division. In this capacity, Ed has global responsibility for leading a holistic, global picture and vision for genomics in the healthy population in a new paradigm of prevention and early detection. In this capacity, he works with direct-to-consumer (DTC) companies, forward-leaning health systems, and innovative insurers and employee wellness programs to help them understand and prepare for the impact of the genomic revolution.  Prior to leading Illumina’s efforts in Precision Health & Screening, Ed led Illumina’s market development activities around national-scale population sequencing initiatives including the Genomics England 100,000 Genome Project, AllOfUS (United States Precision Medicine Initiative), and ~25 similar initiatives around the globe. Before joining Illumina, Ed was a founding team member and led product development and product marketing for Pathway Genomics, a pioneering DTC genomics laboratory.

WORK EXPERIENCE

Market Development – Population Sequencing

Illumina, Inc. | San Diego, CA | September 2014 – Present

Lead Illumina’s global market development efforts for national-scale whole genome sequencing programs.

EDUCATION

Rush University | Chicago, IL

Master of Science (MBA), Health Systems Management, June 1996

Rush University Chairman’s Award – 4.0 GPA

Duke University | Durham, NC

Bachelor of Arts, Public Policy Studies, May 1991

PATENTS AND AWARDS

Saliva sample collection systems, patent # 8,617,487. Awarded December 31, 2013.

US Army Expert Field Medical Badge, for expert proficiency in field medicine, 1992

US Army Honor Graduate, Primary Leadership Development Course, 1994

과거 참여 이력

2017 HIF 기조강연 - 유전체학이 여는 헬스케어의 미래

답글 남기기

crossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram